LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
9/30/2025 | 6/30/2025 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | – | $0 |
| - Cash | $0 | $0 | – | $0 |
| + Debt | $0 | $0 | – | $0 |
| Enterprise Value | – | $0 | – | $0 |
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | – | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | – | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | – | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.14 | – | -0.63 | -7.82 |
| % Growth | – | – | 91.9% | – |
| Operating Cash Flow | – | – | -$0 | -$0 |
| Capital Expenditures | – | – | -$0 | -$0 |
| Free Cash Flow | – | – | -$0 | -$0 |